The DUET trials: etravirine in the management of treatment-experienced HIV-1-infected patients

ISSN： 1758-4310

Source： HIV Therapy, Vol.4, Iss.3, 2010-05, pp. : 265-280

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

The Use of Nucleoside Reverse Transcriptase Inhibitors Sparing Regimens in Treatment-Experienced HIV-1 Infected Patients

Current HIV Research, Vol. 11, Iss. 3, 2013-04 ,pp. : 179-186

Bentham Science Publishers

Access to resources Recommend Favorite

Etravirine: a second-generation NNRTI for treatment-experienced adults with resistant HIV-1 infection

By Minuto Joshua J Haubrich Richard

Future HIV Therapy, Vol. 2, Iss. 6, 2008-11 ,pp. : 525-537

Future Medicine

Access to resources Recommend Favorite

Week 96 Outcomes of Patients With Less Treatment Experience Versus More Treatment Experience Receiving Etravirine in the DUET Trials

Current HIV Research, Vol. 10, Iss. 3, 2012-04 ,pp. : 256-261

Bentham Science Publishers

Access to resources Recommend Favorite

Initiation of therapy with a subcutaneously administered antiretroviral in treatment-experienced HIV-infected patients: understanding physician and patient perspectives

By Horne Rob Cooper Vanessa Fisher Martin

AIDS Care, Vol. 20, Iss. 9, 2008-10 ,pp. : 1029-1038

Routledge Ltd

Access to resources Recommend Favorite

Susceptibility of HIV-1 to Tipranavir and Other Antiretroviral Agents in Treatment-Experienced Patients: The UTILIZE Study

Current HIV Research, Vol. 8, Iss. 4, 2010-06 ,pp. : 347-354

Bentham Science Publishers

Access to resources Recommend Favorite